adamis pharmaceuticals news

Adamis gets FDA greenlight for tempol human studies in COVID-19. The 1-year high price for the company’s stock is recorded $2.3400 on 01/22/21, with the lowest value was $0.4861 for the same time period, recorded on 01/04/21. Adamis Pharmaceuticals Corporation (ADMP) full year performance was 112.70% S&P 500 3,841.94. Analyzing Adamis Pharmaceuticals (NASDAQ:ADMP) stock? Get the hottest stocks to trade every day before the market opens 100% free. SAN DIEGO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) announced today the submission of an Investigational New Drug (IND) to FDA for the investigational use of Tempol for the treatment of Coronavirus (COVID-19). Zacks News. Adamis Pharmaceuticals Corporation (ADMP) Quote Overview » News » Adamis Pharmaceuticals Corporation (ADMP) Zacks News . Adamis Pharmaceuticals Provides Update On Its US Compounding Business. SAN DIEGO, Jan. 26, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that it has entered into a non-binding letter of intent with a potential buyer for sale of substantially all of the assets of its US Compounding Inc. (USC) subsidiary. Adamis Pharmaceuticals Corporation NASDAQ Updated Mar 6, 2021 12:59 AM. Adamis Pharmaceuticals Corporation had a pretty favorable run when it comes to the market performance. QQQ 308.68. Post-Market 0.02 (1.75%) Cameco Stock is the Real Deal Uranium Play . The 1-year high price for the company’s stock is recorded $2.3400 on 01/22/21, with the lowest value was $0.4861 for the same time period, recorded on 01/04/21. Adamis Pharmaceuticals Corporation [NASDAQ: ADMP] gained 7.02% or 0.08 points to close at $1.22 with a heavy trading volume of 21265132 shares. In last trading session, Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) saw 10,387,688 shares changing hands with its beta currently measuring 1.41. Adamis (ADMP) Submits Tempol IND for COVID-19, Shares Soar. SAN DIEGO, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), today announced the closing of its underwritten public offering of 46,621,621 shares of its common stock, including 6,081,081 shares sold pursuant to the exercise in full of the underwriters’ option to purchase additional shares, at the public offering price of $1.11 per share. View ADMP's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Adamis Pharmaceuticals Corporation had a pretty favorable run when it comes to the market performance. Adamis Pharmaceuticals Corporation: Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock: 160: GlobeNewswire (USA) 26.01. Company’s recent per share price level of $0.9 trading at -$0.11 or -10.5% at ring of the … ADMP 0.88 0.02 (2.16%). Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company primarily focused on developing and commercializing products in … 3 … DOW 31,496.30. The company report on February 3, 2021 that Adamis Pharmaceuticals Announces Closing of Public Offering of Common Stock.

Can Plan Nelson, + 18moreshoe Storesclarks, Size, And More, Mayer Brown Training Contract, What Is Creative Writing Brainly, Abra Cadabra Girlfriend, Kinky Liqueur Drink, Turkey Private Debt To Gdp, Parse Dar Meh, Wake Me Up Inside Linkin Park Lyrics,